Search results
Results from the WOW.Com Content Network
Protein-bound paclitaxel was developed by VivoRx which became Abraxis BioScience as the first in its class of drugs to use the nanoparticle albumin bound (nab) technology platform. [14] In 2010, Abraxis was acquired by Celgene, which now markets Abraxane. [15] Total revenue from the sales of Abraxane for 2009 were $314.5 million. [16]
Paclitaxel is one of several cytoskeletal drugs that target tubulin. Paclitaxel-treated cells have defects in mitotic spindle assembly, chromosome segregation, and cell division. Unlike other tubulin-targeting drugs, such as colchicine, that inhibit microtubule assembly, paclitaxel stabilizes the microtubule polymer and protects it from ...
This is a list of chemotherapeutic agents, also known as cytotoxic agents or cytostatic drugs, that are known to be of use in chemotherapy for cancer. This list is organized by type of agent, although the subsections are not necessarily definitive and are subject to revision.
ABRAXANE ® Phase III Study of Patients with Metastatic Pancreatic Cancer Published in New England Journal of Medicine BOUDRY, Switzerland--(BUSINESS WIRE)-- Celgene International Sàrl, a wholly ...
Taxoids are a class of derivatives from taxol, [1] that is, paclitaxel.They were developed for their anticancer chemotherapeutic properties. Taxoids are usually treated as synonymous with taxanes; for example, a major medical dictionary defines the two terms with the same definition phrasing, [2] and in another the phrasing varies slightly but conveys nearly identical meaning.
For premium support please call: 800-290-4726 more ways to reach us
In 2013, the U.S. Food and Drug Administration approved protein-bound paclitaxel (also known as nab-paclitaxel, sold as Abraxane) used with gemcitabine. This regimen may be less toxic—but perhaps less effective—alternative to FOLFIRINOX for treating late-stage pancreatic cancer.
Immunology therapeutic classes. ... Revlimid, an oral immunomodulatory drug for the treatment of multiple myeloma. ... Abraxane, a protein-bound chemotherapy product.